Beta-O2 Technologies For Profit

Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.
Technology: Other
Industry: Regenerative medicine
Headquarters: Others
Total Funding: $8.5M
Estimated Revenue: Less than $1M
Last Funding Type: Venture - Series Unknown

Visit Website
press@beta-o2.com
Register and Claim Ownership